Added to YB: 2025-11-27
Pitch date: 2025-11-26
LOVE.V [neutral]
Cannara Biotech Inc.
+5.26%
current return
Author Info
Wolf of Oakville takes a magnifying glass to Canadian small cap stocks. Sign up for the newsletter.
Company Info
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada.
Market Cap
CAD 164.2M
Pitch Price
CAD 1.71
Price Target
N/A
Dividend
N/A
EV/EBITDA
6.75
P/E
12.36
EV/Sales
1.79
Sector
Personal Care Products
Category
growth
Cannara Biotech ($LOVE.V) FINS Review
LOVE.V (earnings): Cannabis co w/ 20 consecutive qtrs of 20%+ YoY growth, reaching $107M rev (31% up) & $13M net income (2x last yr). 44% gross margin (+800bps). Strong OCF $20M (+87%). Using only 50% capacity, gaining market share across provinces. 1.5x P/S, 12x P/E. Liquidity concerns w/ 0.83 quick ratio.
Read full article (4 min)